MOTS-c
Also known as: Mitochondrial ORF of the 12S rRNA Type-c
A mitochondrial-derived peptide dubbed an 'exercise mimetic' that reverses age-related insulin resistance and enhances fat oxidation even in sedentary individuals.
Reviewed by Dr. Sarah Mitchell, PharmD, BCPS
Lead Researcher · 12+ years in peptide therapeutics
~4–6 hours
5–10 mg weekly
Subcutaneous injection
Mechanism of Action
Activates AMPK signaling and folate/methionine metabolism to shift cellular energy from glucose dependency to fat oxidation, improving metabolic homeostasis.
Key Research Areas
Frequently Asked Questions
What is MOTS-c?▾
How does MOTS-c work?▾
What is the recommended dosage for MOTS-c?▾
What is the half-life of MOTS-c?▾
Is MOTS-c FDA approved?▾
Research Disclaimer
The information provided about MOTS-c is for educational purposes only and is not intended as medical advice. Always consult a qualified healthcare professional before starting any peptide protocol. Products discussed have not been evaluated by the FDA unless explicitly noted.